Louise Gray

Dr. Louise Gray is a Research Fellow in the Department of Biomedical Engineering at the University of Strathclyde, United Kingdom, specializing in electrochemical biosensor development for medical diagnostics. Her work bridges material science and clinical applications with active collaborations across healthcare and engineering disciplines.

Her research focuses on biosensor innovation for critical medical challenges, particularly antibiotic resistance detection and neurotransmitter analysis. Key investigations examine how electrode roughness, self-assembled monolayer composition, and thin-film manufacturing techniques impact sensor performance, aiming to create low-cost, mass-producible diagnostic platforms. Current projects emphasize practical applications in point-of-care testing and chronic disease management.

Recent publications demonstrate her trend toward translational engineering solutions, with 2019-2020 work establishing foundational principles for DNA-based antibiotic resistance sensors and dopamine-detecting carbon electrodes. Both studies highlight material-property optimization for real-world diagnostic accuracy, showing strong citation impact (62 and 32 Scopus citations respectively) and significant Mendeley readership.

She actively contributes to major funded initiatives including a Wellcome Trust project (2025) on socially progressive technological research and an NIHR-funded Systems Engineering Innovation hub (2023-2025) addressing multiple long-term conditions. Her collaborative approach spans behavioral science, user experience design, and mobile health technologies, recently demonstrated at the May 2024 Health and Care Futures workshop where she engaged with clinicians, engineers, and policy stakeholders.

Gray maintains strong research visibility through her ORCID profile (0000-0003-2020-4388) and demonstrates consistent output in high-impact journals like Biosensors and Bioelectrochemistry, with work downloaded over 250 times across university repositories.